The Effect of Blood-Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose-Derived Mesenchymal Stem Cells Originated from Three Different Locations

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Positive markers</td><td class="align_center">CD105 PerCP-Cy5.5/CD73 APC/CD90 FITC</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Negative cocktail</td><td class="align_center">CD45/CD34/CD11b/CD19/HLA-DR</td></tr><tr><td class="align_left">Isotype control</td><td class="align_center">mIgG1, <i>κ</i> PerCP-Cy5.5/mIgG1, <i>κ</i> APC/mIgG1, <i>κ</i> FITC (for positive markers)<br/>mIgG1, <i>κ</i> PE/mIgG2a, <i>κ</i> PE (for negative cocktail)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Stem Cells International

tab1

Table 1

Table 1: The Effect of Blood-Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose-Derived Mesenchymal Stem Cells Originated from Three Different Locations 

Table 1 | The Effect of Blood-Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose-Derived Mesenchymal Stem Cells Originated from Three Different Locations 